Plasma and Intracellular Concentrations in HIV-Infected Patients Requiring Hemodialysis Dosed With Tenofovir Disoproxil Fumarate and Emtricitabine

被引:5
|
作者
Slaven, James E. [1 ]
Decker, Brian S. [2 ]
Kashuba, Angela D. M. [3 ]
Atta, Mohamed G. [4 ]
Wyatt, Christina M. [5 ]
Gupta, Samir K. [6 ]
机构
[1] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Div Nephrol, Indianapolis, IN 46202 USA
[3] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Ctr AIDS Res, Chapel Hill, NC USA
[4] Johns Hopkins Sch Med, Div Nephrol, Baltimore, MD USA
[5] Icahn Sch Med Mt Sinai, Div Nephrol, New York, NY 10029 USA
[6] Indiana Univ Sch Med, Div Infect Dis, Indianapolis, IN 46202 USA
关键词
PHARMACOKINETICS; TRIAL;
D O I
10.1097/QAI.0000000000001106
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:e8 / e10
页数:3
相关论文
共 50 条
  • [42] Pharmacokinetics of Atazanavir/Ritonavir Among HIV-infected Thai Children Concomitantly Taking Tenofovir Disoproxil Fumarate
    Bunupuradah, Torsak
    Techasaensiri, Chonnamet
    Keadpudsa, Siriwan
    Thammajaruk, Narukjaporn
    Srimuan, Amornrat
    Sahakijpicharn, Thaintip
    Prasitsuebsai, Wasana
    Ananworanich, Jintanat
    Puthanakit, Thanyawee
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (12) : E316 - E319
  • [43] Kidney etubular dysfunction and decline in renal function in HIV-infected Chinese receiving tenofovir disoproxil fumarate
    Lui, Chung Yan Grace
    Chan, Pui Chung Denise
    Cheung, C. Y. Simon
    Lee, Man Po
    Naftalin, Claire
    Chan, Ka Lun
    Wong, Ngai Sze
    Lee, Shui Shan
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [44] Cumulative Tenofovir Disoproxil Fumarate Exposure is Associated With Biomarkers of Tubular Injury and Fibrosis in HIV-Infected Men
    Jotwani, Vasantha
    Scherzer, Rebecca
    Estrella, Michelle M.
    Jacobson, Lisa P.
    Witt, Mallory D.
    Palella, Frank
    Macatangay, Bernard
    Bennett, Michael
    Parikh, Chirag R.
    Ix, Joachim H.
    Shlipak, Michael
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 73 (02) : 177 - 181
  • [45] Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis
    Das, Moupali
    Ting, Jie
    Shreay, Sanatan
    Bush, Staci
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 173 (06) : 506 - 507
  • [46] Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis
    Walensky, Rochelle P.
    Horn, Tim
    McCann, Nicole C.
    Freedberg, Kenneth A.
    Paltiel, A. David
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 172 (09) : 583 - +
  • [47] Tenofovir and emtricitabine concentrations in hair are comparable between individuals on tenofovir disoproxil fumarate versus tenofovir alafenamide-based ART
    Okochi, Hideaki
    Louie, Alexander
    Nhi Phung
    Zhang, Kevin
    Tallerico, Regina M.
    Kuncze, Karen
    Spinelli, Matthew A.
    Koss, Catherine A.
    Benet, Leslie Z.
    Gandhi, Monica
    [J]. DRUG TESTING AND ANALYSIS, 2021, 13 (07) : 1354 - 1370
  • [48] Effectiveness and safety of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet combination among HIV-infected patients in Turkey: results from a real world setting
    Mete, Bilgul
    Gunduz, Alper
    Karaosmanoglu, Hayat Kumbasar
    Gumuser, Fatma
    Bolukcu, Sibel
    Yildiz, Dilek Sevgi
    Aydin, Ozlem Altuntas
    Bilge, Bilgenur
    Dokmetas, Ilyas
    Tabak, Fehmi
    [J]. AFRICAN HEALTH SCIENCES, 2021, 21 (04) : 1593 - 1602
  • [49] Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants
    Flynn, Patricia M.
    Mirochnick, Mark
    Shapiro, David E.
    Bardeguez, Arlene
    Rodman, John
    Robbins, Brian
    Huang, Sharon
    Fiscus, Susan A.
    Van Rompay, Koen K. A.
    Rooney, James F.
    Kearney, Brian
    Mofenson, Lynne M.
    Watts, D. Heather
    Jean-Philippe, Patrick
    Heckman, Barbara
    Thorpe, Edwin, Jr.
    Cotter, Amanda
    Purswani, Murli
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (12) : 5914 - 5922
  • [50] Switching From Twice-Daily Raltegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine to Once-Daily Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed, HIV-1-Infected Subjects: 48 Weeks Data
    Mills, A.
    Crofoot, G.
    Ortiz, R.
    Rashbaum, B.
    Towner, W.
    Ward, D.
    Brinson, C.
    Kulkarni, R.
    Garner, W.
    Ebrahimi, R.
    Cao, H.
    Cheng, A.
    Szwarcberg, J.
    [J]. HIV CLINICAL TRIALS, 2014, 15 (02): : 51 - 56